Skip to content
AiSeekAiSeek
Sign in

Company

Nexentis Technologies Inc.

FollowOpen structure mapAsk about thisResearch this company

Structure of Nexentis Technologies Inc.

Nexentis Technologies Inc.

Company

1 connections
OwnershipInvestment and holdings1 of 2
Relationship began2026
Nexentis Technologies Inc.Company · 1 connections
Layer 1

OwnershipInvestment and holdings1

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

  • Nexentis Technologies Inc.owns →MitoCareX Bio
    Company · MitoCareX BioEvidence 2
    Fact90%
    View evidence
    • CompanyGlobeNewswire public company news2026-10-07 19:32
      Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company.
      View source
    • CompanyGlobeNewswire public company news2026-10-07 19:32
      MitoCareX Bio Ltd. (“MitoCareX”), its wholly owned subsidiary
      View source
  • Nexentis Technologies Inc.invests in →solar projects
    Facility · solar projectsEvidence 1
    Fact90%
    View evidence
    • CompanyGlobeNewswire public company news2026-10-07 19:32
      The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.
      View source

Showing 1 to 2 of 2

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1
invests insolar projects

The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.

GlobeNewswire public company news · 2026-10-07 19:32

View evidence
  • CompanyGlobeNewswire public company news2026-10-07 19:32
    The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.
    View source
FactEvidence 1
number of solar projects in which it is the lead investorfour

The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.

GlobeNewswire public company news · 2026-10-07 19:32

View evidence
  • CompanyGlobeNewswire public company news2026-10-07 19:32
    The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.
    View source
FactEvidence 2
ownsMitoCareX Bio

Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company.

GlobeNewswire public company news · 2026-10-07 19:32

View evidence
  • CompanyGlobeNewswire public company news2026-10-07 19:32
    Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company.
    View source
  • CompanyGlobeNewswire public company news2026-10-07 19:32
    MitoCareX Bio Ltd. (“MitoCareX”), its wholly owned subsidiary
    View source

Showing 1 to 3 of 3

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Not available: Company signals · Financials · Filings · Guidance